Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford University and Novo Nordisk announced the expansion of their international fellowship programme to support research within the fields of diabetes and metabolism.

Logo of Novo Nordisk (University of Oxford).

Additional funding has been provided by Novo Nordisk to support another 20 Fellows, bringing the total number of Fellows to 32. The fellowships are aimed at early career postdoctoral researchers and clinicians wishing to undertake a PhD (DPhil). The Fellowship programme aims to support the development of a new generation of exceptional young diabetes researchers, who will become future leaders in the field, while further developing scientific excellence within diabetes and ultimately improving the lives of patients.

In announcing this expansion of the fellowship programme, Mads Krogsgaard Thomsen, Novo Nordisk’s Chief Science Officer, said “We are proud to continue our association with University of Oxford and with this fellowship programme, which broadens our network at top academic institutions while supporting cutting-edge diabetes research.” Peter Kurtzhals, senior vice president of Global Research at Novo Nordisk, added that “We want to promote scientific excellence within diabetes, and one important way of doing this is to support the education of young, exceptional research talent within this area.”     

Full details of the fellowships are available on the RDM website. The next call for Fellowships will be announced in late February 2016. Any enquiries should be directed to Dr Ruth McCaffrey.

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

Study reveals ‘stop-eating’ response to DNA damage

A new study from the Patel Group sheds light on the mechanism by which DNA damage suppresses appetite, a finding with implications for understanding the appetite lowering side-effects of chemotherapy.

$2m awarded to explore the role of ancestry in vaccine response

The Lymph nodE single-cell Genomics AnCestrY (LEGACY) Network will create an ethnically diverse single-cell atlas of the response to commonly used vaccines such as flu vaccines with a focus on responses in lymph nodes.

Joe Frost wins 2021 RDM graduate prize

Many congratulations to Dr Frost.

Major research network to investigate body clock and stroke

The University of Oxford is part of a new international research network to investigate the interactions between the biology of the body's internal clock and the disordered physiological processes associated with stroke.